A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancer.
Saved in:
| Title: | A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancer. |
|---|---|
| Authors: | Juarez TM; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neuro-Oncology, Santa Monica, California, USA., Gill JM; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neuro-Oncology, Santa Monica, California, USA., Heng A; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neuro-Oncology, Santa Monica, California, USA., Carrillo JA; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neuro-Oncology, Santa Monica, California, USA., Wagle N; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neuro-Oncology, Santa Monica, California, USA., Nomura N; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neuro-Oncology, Santa Monica, California, USA., Nguyen M; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neuro-Oncology, Santa Monica, California, USA., Truong J; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neuro-Oncology, Santa Monica, California, USA., Dobrawa L; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neuro-Oncology, Santa Monica, California, USA., Sivakumar W; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neurosurgery, Santa Monica, California, USA., Barkhoudarian G; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neurosurgery, Santa Monica, California, USA., Kelly DF; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neurosurgery, Santa Monica, California, USA., Kesari S; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Neuro-Oncology, Santa Monica, California, USA. |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2024 Mar 30; Vol. 6 (1), pp. vdae049. Date of Electronic Publication: 2024 Mar 30 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2632-2498 |
|---|---|
| DOI: | 10.1093/noajnl/vdae049 |
